Endo to flag Opana ER painkiller's risks, under NY settlement

NEW YORK (Reuters) - Endo International Plc agreed to stop marketing its Opana ER painkiller pill as crush-resistant, and stop downplaying the risks of addiction associated with the narcotic, under a settlement with New York state announced on Thursday.

http://ift.tt/1UBIjDL

from Reuters: Health News
via animenewspro